Hepatitis A: disease burden and current childhood vaccination strategies in the United States
Related Experiment Video
Updated: Jul 8, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Mary Beth Koslap-Petraco1, Mitchell Shub, Richard Judelsohn
1Suffolk County Department of Health Services, Hauppauge, NY 11788, USA. MaryBeth.Petraco@suffolkcountyny.gov
Abstract:
Hepatitis A can be a serious disease and represents a substantial health and economic burden. In recent years, a decline in the number of cases of hepatitis A has been observed, which has been attributed in part to the implementation of vaccination policies in states with high disease incidence. In May 2006, the Advisory Committee on Immunization Practices published updated recommendations to include routine hepatitis A vaccination for all children beginning at 12 to 23 months of age. In this review, information on hepatitis A disease burden is presented with a discussion on the new recommendations and implementation of hepatitis A vaccination.
Related Concept Videos
Hepatitis
Vaccinations
Smallpox
Viral Hepatitis I: Introduction
Poliomyelitis
Yellow Fever